PATHCARE LABS PVT LTD.

Regional Laboratory -
Jeevan Jyot Building, 1st Floor, Opp. Ghatkopar
Railway Station , Ghatkopar (West) , Mumbai - 400086
Ph:- 04061216121

Patient Name : Mrs. ARCHANA BISWAL Reg. No. : 00722411190005

Age and Sex : 27 Yrs / Female PCC Code : PCL-MH-1643
Referring Doctor : Self Sample Drawn Date : 19-Nov-2024 12:21 PM
Referring Customer : N/A Registration Date : 19-Nov-2024 06:25 PM
Vial ID : R0214163 Report Date : 19-Nov-2024 08:13 PM
Sample Type : WB-EDTA Report Status : Final Report
Client Address : Room No 302, Mauli Krupa, Manpada Road, Sagaon, Dombivali(E)

HEMATOLOGY
PATHCHECK SUPREME
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)

Complete Blood Count (CBC)

Haemoglobin 8.7 g/dL 12.0-15.0 Colorimetric
RBC Count 4.2 10^12/L 3.8-4.8 Electrical Impedance
Haematocrit (HCT) 27.2 % 36-46 Calculated
MCV 63.9 fl 83-101 RBC Histogram
MCH 20.5 pg 27-32 Calculated
MCHC 32.0 g/dL 31.5-34.5 Calculated
RDW-CV 15.3 % 11.6-14.0 RBC Histogram
Platelet Count 301 10^9/L 150-410 Electrical
Impedance/Microscopy
WBC count, Total 7.4 10^9/L 4.0-10.0 Impedance
Neutrophils 67.0 % 40-70 Microscopy
Neutrophil-Absolute Count 5.0 10^9/L 2.0-7.0 Calculated
Lymphocytes 28.0 % 20-40 Microscopy
Lymphocytes-Absolute Count 2.1 10^9/L 1.0-3.0 Calculated
Monocytes 3.0 % 2-10 Microscopy
Monocytes-Absolute Count 0.2 10^9/L 0.2-1.0 Calculated
Eosinophils 2.0 % 1-6 Microscopy
Eosinophils-Absolute Count 0.1 10^9/L 0.02-0.5 Calculated
Basophils 0.0 % 0-2 Microscopy
Basophils-Absolute Count 0.0 10^9/L 0.0-0.3 Calculated
Others 0.0 % 00 Microscopy
Remarks RBC- Mild Microcytosis Mild hypochromia Mild Anisocytosis. WBC-Normal. Platelets-
Adequate.
Sample is Processed on Automated CBC Analyzer
Note: Haematocrit (HCT) is derived from calculated MCV based on RBC Histogram as per Manufacturer's Manual

*Erythrocyte Sedimentation Rate 11 mm in 1hr 12 or less Westergren

(ESR) method
Comment:
Conditions that may be associated with a highly elevated ESR include the Hypersensitivity Vasculitis, Giant Cell Arteritis, Waldenstrom Macroglobulinemia, Polymyalgia Rheumatic, Metastatic
Cancer, Chronic infection, Hyperfibrogenemia etc.

Page 1 of 7
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
 PATHCARE LABS PVT LTD. Regional Laboratory -
Jeevan Jyot Building, 1st Floor, Opp. Ghatkopar
Railway Station , Ghatkopar (West) , Mumbai - 400086
Ph:- 04061216121

Patient Name : Mrs. ARCHANA BISWAL Reg. No. : 00722411190005

Age and Sex : 27 Yrs / Female PCC Code : PCL-MH-1643
Referring Doctor : Self Sample Drawn Date : 19-Nov-2024 12:21 PM
Referring Customer : N/A Registration Date : 19-Nov-2024 06:25 PM
Vial ID : R0214163, R0214161, R0214166 Report Date : 19-Nov-2024 09:42 PM
Sample Type : WB-EDTA , Plasma-Sodium Fluori Report Status : Final Report
Client Address : Room No 302, Mauli Krupa, Manpada Road, Sagaon, Dombivali(E)

CLINICAL BIOCHEMISTRY
PATHCHECK SUPREME
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)

*Glycosylated 5.4 % Normal: < 5.7 Enzymatic

Hemoglobin(GHb/HbA1c) Pre-Diabetic: 5.7-6.4~
Diabetic: >= 6.5
*Glycosylated Hemoglobin 35.52 mmol/mol Calculated
*Mean Blood Glucose 108.28 mg/dL 90 - 120 : Excellent Control 121 - Calculated
150 : Good Control 151 - 180 :
Average Control 181 - 210 : Action
Suggested >211 :Panic Value
Comments:

HbA1c is an indicator of glycemic control. HbA1c represents average Glycemia over the past six to eight weeks. Glycation of Hemoglobin occurs over the entire
120 day life span of the Red Blood Cell, but within this 120 days. Clinical studies suggest that a patient in stable control will have 50% of their HbA1c formed in
the month before sampling, 25% in the month before that, and the remaining 25% in months two to four.
Mean Plasma Glucose mg/dL = 28.7 x A1C - 46.7. Correlation between HbA1c and Mean Plasma Glucose (MPG) is not "perfect" but rather only this means that
to predict or estimate average glucose from HbA1c or vice-versa is not "perfect" but gives a good working ballpark estimate.
Afternoon and evening results correlate more closely to HbA1c than morning results, perhaps because morning fasting glucose levels vary much more than
daytime Glucose levels, which are easier to predict and control. As per IFCC recommendations 2007, HbA1c being reported as above maintaining traceability to
both IFCC (mmol/mol) & NGSP (%) units.
Reference: ADA (American Diabetic Assosciation) Guidelines 2023.

*Glucose-Blood-Fasting 82.8 mg/dL Normal < 100 Hexokinase

Pre-diabetic 100-125
Diabetic >= 126
Comments:

Glucose is the major carbohydrate present in blood. Its oxidation in the cells is the source of energy for the body. Increased levels of Glucose are found in
Diabetes Mellitus, Hyperparathyroidism, Pancreatitis and renal failure.
Decreased levels are found in Insulinoma, Hypothyroidism, Hypopituitarism and extensive Liver disease

Biological Reference Interval : Source: American Diabetic Association, Diabetes Care 2018:41 (Suppl.1) S13-S27

Page 2 of 7
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
 PATHCARE LABS PVT LTD. Regional Laboratory -
Jeevan Jyot Building, 1st Floor, Opp. Ghatkopar
Railway Station , Ghatkopar (West) , Mumbai - 400086
Ph:- 04061216121

Patient Name : Mrs. ARCHANA BISWAL Reg. No. : 00722411190005

Age and Sex : 27 Yrs / Female PCC Code : PCL-MH-1643
Referring Doctor : Self Sample Drawn Date : 19-Nov-2024 12:21 PM
Referring Customer : N/A Registration Date : 19-Nov-2024 06:25 PM
Vial ID : R0214163, R0214161, R0214166 Report Date : 19-Nov-2024 09:42 PM
Sample Type : WB-EDTA , Plasma-Sodium Fluori Report Status : Final Report
Client Address : Room No 302, Mauli Krupa, Manpada Road, Sagaon, Dombivali(E)

CLINICAL BIOCHEMISTRY
PATHCHECK SUPREME
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
*Thyroid Stimulating Hormone 1.4377 µIU/mL 0.4-4.2 (Test performed on 4th CMIA
(TSH) Generation TSH kit)
Biological Reference Intervals : TSH(μlU/mL)
Pregnancy (As per American Thyroid Association)
1 Trimester 0.10-2.50
2 Trimester 0.2-3.00
3 Trimester 0.3-3.00

Interpretation:

Assay results should be interpreted in context to the clinical condition and associated results of other investigations.
Previous treatment with Corticosteroid therapy may result in lower TSH levels while Thyroid hormone levels are normal.
Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test.
Abnormal Thyroid test findings often found in critically ill clients should be repeated after the critical nature of the condition is resolved.
The production, circulation, and disposal of Thyroid hormone are altered throughout the stages of pregnancy.

Result rechecked and verified for abnormal cases.

*** End Of Report ***

Page 3 of 7
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
 PATHCARE LABS PVT LTD. Regional Laboratory -
Jeevan Jyot Building, 1st Floor, Opp. Ghatkopar
Railway Station , Ghatkopar (West) , Mumbai - 400086
Ph:- 04061216121

Patient Name : Mrs. ARCHANA BISWAL Reg. No. : 00722411190005

Age and Sex : 27 Yrs / Female PCC Code : PCL-MH-1643
Referring Doctor : Self Sample Drawn Date : 19-Nov-2024 12:21 PM
Referring Customer : N/A Registration Date : 19-Nov-2024 06:25 PM
Vial ID : R0214166 Report Date : 19-Nov-2024 09:42 PM
Sample Type : Serum Report Status : Final Report
Client Address : Room No 302, Mauli Krupa, Manpada Road, Sagaon, Dombivali(E)

CLINICAL BIOCHEMISTRY
PATHCHECK SUPREME
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)

Liver Function Test (LFT)

Bilirubin Total 0.30 mg/dL 0.2-1.2 Diazonium Salt
Bilirubin Direct 0.12 mg/dL 0-0.5 Diazo Reaction
Bilirubin Indirect 0.18 mg/dL 0.2 - 1.0 Calculated
Alkaline Phosphatase (ALP) 103.0 U/L 40-150 Para-Nitrophenyl-
phosphate
Aspartate Aminotransferase (SGOT) 20.0 U/L 11-34 NADH w/o P-5’-P
Alanine Transaminase (ALT/SGPT) 13.0 U/L 0-34 NADH w/o P-5’-P
Gamma Glutamyl Transferase 21 U/L 12-64 L-g-g-3-Carboxy-
(GGT) 4-Nitroanilide subs
Protein Total 7.7 g/dL 6.0-7.8 Biuret
Albumin 4.5 g/dL 3.5-5.0 Bromcresol green
Globulin 3.2 g/dl 2.5 - 3.8 Calculated
Albumin / Globulin Ratio 1.4 1.0 - 2.1 Calculated
*Liver function tests are blood tests used to help diagnose and monitor Liver disease or damage.
*Screen for Liver infections, such as Hepatitis, monitor possible side effects of medications
*Measure the severity of a disease, particularly scarring of the Liver (Cirrhosis)
*Alanine Transaminase (ALT)- an enzyme found in the Liver that helps your body metabolize protein. When the Liver is damaged, ALT is released into
the bloodstream and levels increase.
*Aspartate Transaminase (AST)- an enzyme that helps metabolize Alanine, an amino acid. Like ALT, AST is normally present in blood at low levels. An
increase in AST levels may indicate Liver damage or disease or Muscle damage.
*Alkaline Phosphatase (ALP)- an enzyme in the Liver, bile ducts and bone. Higher-than-normal levels of ALP may indicate liver damage or disease,
such as a blocked bile duct, or certain bone diseases.
*Albumin and Total Protein- Albumin is one of several proteins made in the Liver. Your body needs these proteins to fight infections and to perform
other functions. Lower-than-normal levels of albumin and total protein might indicate Liver damage or disease
*Bilirubin- a substance produced during the normal breakdown of red blood cells. Bilirubin passes through the liver and is excreted in stool. Elevated
levels of bilirubin (jaundice) might indicate liver damage or disease or certain types of anemia.
*Gamma-Glutamyltransferase (GGT)- GGT is an enzyme in the blood. Higher-than-normal levels may indicate liver or bile duct damage.

Result rechecked and verified for abnormal cases.

*** End Of Report ***

Page 4 of 7
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
 PATHCARE LABS PVT LTD. Regional Laboratory -
Jeevan Jyot Building, 1st Floor, Opp. Ghatkopar
Railway Station , Ghatkopar (West) , Mumbai - 400086
Ph:- 04061216121

Patient Name : Mrs. ARCHANA BISWAL Reg. No. : 00722411190005

Age and Sex : 27 Yrs / Female PCC Code : PCL-MH-1643
Referring Doctor : Self Sample Drawn Date : 19-Nov-2024 12:21 PM
Referring Customer : N/A Registration Date : 19-Nov-2024 06:25 PM
Vial ID : R0214166 Report Date : 19-Nov-2024 09:42 PM
Sample Type : Serum Report Status : Final Report
Client Address : Room No 302, Mauli Krupa, Manpada Road, Sagaon, Dombivali(E)

CLINICAL BIOCHEMISTRY
PATHCHECK SUPREME
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)

Lipid Profile
Cholesterol Total 230 mg/dL Adult: Desirable<200 mg/dL, Enzymatic
Borderline: 200 – 239 mg/dL,
High:>240 mg/dL
Cholesterol HDL 41.22 mg / dL 40 - 60 Direct
Homogenous
Cholesterol - LDL 153.78 mg/dL <100 Optimal Calculated
Cholesterol VLDL 35 mg/dL 7-40 Calculated
Non-HDL cholesterol 188.78 mg/dL Optimal < 130 Calculated
Triglycerides 175.0 mg/dL Normal: <150 Glycerol
Borderline High: 150–199 Phosphate
High: 200–499 Oxidase
Very High >500
Cholesterol Total/Cholesterol HDL 5.6 0 - 4.0 Calculated
Ratio
Cholesterol LDL/Cholesterol HDL 3.7 0 - 3.5 Calculated
COMMENTS: Therapeutic target levels of lipids as per NCEP – ATP III recommendations:
Total Cholesterol (mg/dL) <200 - Desirable, 200-239 - Borderline High, >240 - High
HDL Cholesterol (mg/dL) <40 - Low, >60 - High
LDL Cholesterol (mg/dL) <100 Optimal, [Primary Target of Therapy], 100-129 - Near Optimal/Above Optimal,
130-159 - Borderline High, 160-189 - High, >190 Very High
Serum Triglycerides (mg/dL) <150 Normal, 150-199 Borderline High, 200-499 High, >500 Very High
NCEP recommends lowering of LDL Cholesterol as the primary therapeutic target with Lipid lowering agents, however, if Triglycerides remain >200 mg/dL after LDL goal is reached, set
secondary goal for non-HDL Cholesterol (total minus HDL) 30 mg/dL higher than LDL goal.
When Triglyceride level is > 400 mg/dL, Friedewald Equation is not applicable for calculation of LDL & VLDL. Hence the calculated values are not provided for such samples.
ATP III Guidelines:
Risk Category LDL Goal LDL Level at Which to LDL Level at Which to Consider Drug Therapy
Initiate Therapeutic
Lifestyle Changes (TLC)
CHD or CHD <100 mg/dL >100 mg/dL >130 mg/dL (100-129 mg/dL: drug optional)*
RiskEquivalents(10-year risk
>20%)
2+ Risk Factors <130 mg/dL >130 mg/dL 10-year risk 10-20%: >130 mg/dL 10-year risk <10%:>160mg/dL
(10-year risk <20%)
0-1 Risk Factor <160 mg/dL >160 mg/dL >190 mg/dL (160-189 mg/dL: LDL-lowering drug optional)

Result rechecked and verified for abnormal cases.

*** End Of Report ***

Page 5 of 7
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
 PATHCARE LABS PVT LTD. Regional Laboratory -
Jeevan Jyot Building, 1st Floor, Opp. Ghatkopar
Railway Station , Ghatkopar (West) , Mumbai - 400086
Ph:- 04061216121

Patient Name : Mrs. ARCHANA BISWAL Reg. No. : 00722411190005

Age and Sex : 27 Yrs / Female PCC Code : PCL-MH-1643
Referring Doctor : Self Sample Drawn Date : 19-Nov-2024 12:21 PM
Referring Customer : N/A Registration Date : 19-Nov-2024 06:25 PM
Vial ID : R0214166 Report Date : 19-Nov-2024 09:42 PM
Sample Type : Serum Report Status : Final Report
Client Address : Room No 302, Mauli Krupa, Manpada Road, Sagaon, Dombivali(E)

CLINICAL BIOCHEMISTRY
PATHCHECK SUPREME
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)

Iron Deficiency Profile-II

Iron 21 µg/dL 50-170 Ferene
Iron Binding Capacity - Total (TIBC) 449 µg/dL 250-450 Calculated
Transferrin 314.1 mg/dL 176 - 280 Calculated
% Iron Saturation 5 % 20 - 50 Calculated
Iron Iron found in the blood is mainly present in the hemoglobin of the RBCs. Its role in the body is mainly in the transportation. Iron is absorbed in the Small
Intestine, and bound to a globulin in the plasma called Transferrin and transported to the Bone Marrow for the formation of Hemoglobin. Increased serum
levels are found in Hemolytic Anemias, Hepatitis, Lead and Iron poisoning. Decreased serum levels are found in Anemias caused by Iron Deficiency due to
insufficient intake or absorption of Iron, chronic blood loss, late pregnancy and Cancer

TIBC The serum TIBC varies in disorders of Iron metabolism. In Iron-deficiency Anemia the TIBC is elevated and the transferrin saturation is lowered to 15% or
less. Low serum Iron associated with low TIBC is characteristic of the anemia of chronic disorders, malignant tumors, and infections.

*Calcium 9.00 mg/dl 8.4-10.2 Arsenazo III

Complex
Interpretation:

Category Normal Ref. Range

Premature 6.2 mg/dL to 11.0 mg/dL
0 to 10 days 7.6 mg/dL to 10.4 mg/dL
10 days to 24 months 9.0 mg/dL to 11.0 mg/dL
Child 2 to 12 years 8.8 mg/dL to 10.8 mg/dL
Adult 8.4 mg/dL to 10.2 mg/dL
Male > 60 years 8.8 mg/dL to 10.0 mg/dL

Comments:
* Calcium in the body is found mainly in the bones (approximately 99%). In serum, Calcium exists in a free ionised form and in bound form (with Albumin). Hence, a
decrease in Albumin causes lower Calcium levels and vice-versa.
* Calcium levels in serum depend on the Parathyroid Hormone.
* Increased Calcium levels are found in Bone tumors, Hyperparathyroidism. decreased levels are found in Hypoparathyroidism, renal failure, Rickets.

Result rechecked and verified for abnormal cases.

*** End Of Report ***

Page 6 of 7
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
 PATHCARE LABS PVT LTD. Regional Laboratory -
Jeevan Jyot Building, 1st Floor, Opp. Ghatkopar
Railway Station , Ghatkopar (West) , Mumbai - 400086
Ph:- 04061216121

Patient Name : Mrs. ARCHANA BISWAL Reg. No. : 00722411190005

Age and Sex : 27 Yrs / Female PCC Code : PCL-MH-1643
Referring Doctor : Self Sample Drawn Date : 19-Nov-2024 12:21 PM
Referring Customer : N/A Registration Date : 19-Nov-2024 06:25 PM
Vial ID : R0214166 Report Date : 19-Nov-2024 09:42 PM
Sample Type : Serum Report Status : Final Report
Client Address : Room No 302, Mauli Krupa, Manpada Road, Sagaon, Dombivali(E)

CLINICAL BIOCHEMISTRY
PATHCHECK SUPREME
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)

Kidney Function Test (KFT) - III

Creatinine 0.6 mg/dL 0.6-1.1 Kinetic Alkaline
Picrate
Urea 12.8 mg/dL 15.0-40.0 Calculated
Uric Acid 5.7 mg/dL 2.6-6.0 Uricase

Correlate Clinically. Result rechecked and verified for abnormal cases.

*** End Of Report ***

Page 7 of 7
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.